Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-06

Clinical Trial Update: A Study of RBT-9 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease [Phase 1]

View source ↗

Summary

Phase 1 trial of RBT-9 in healthy volunteers and individuals with chronic kidney disease (Stage 3/4 CKD) has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RBT-9 (RBT-9)

Snippet

Sponsor: Renibus Therapeutics, Inc. | Conditions: Healthy Volunteers, Chronic Kidney Disease | Phase 1 | Status: COMPLETED | Results posted: 2025-01-06